A Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer

Acquired resistance to aromatase inhibitors (AIs) remains a major clinical problem in the treatment of estrogen receptor-positive (ER+) breast cancer. We and others have previously reported widespread changes in DNA methylation using breast cancer cell line models of endocrine resistance. Here, we s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Horm Cancer
Autores principales: Nayak, Shweta R, Harrington, Emily, Boone, David, Hartmaier, Ryan, Chen, Jian, Pathiraja, Thushangi N., Cooper, Kristine L., Fine, Jeffrey L., Sanfilippo, Joseph, Davidson, Nancy E., Lee, Adrian V., Dabbs, David, Oesterreich, Steffi
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2015
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4807402/
https://ncbi.nlm.nih.gov/pubmed/26113056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-015-0230-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares